Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2239 of 5804
-
Experimental RNA vaccine takes on advanced lung cancer
⭐️ VACCINE ⭐️ Recruiting nowThis is an open-label, single-arm, non-randomized, single-center, prospective phase 1 clinical trial. The study will evaluate the safety, tolerability, and preliminary antitumor activity of IMP3-saRNA (YMN-136) vaccine in patients with advanced non-small cell lung cancer. IMP3-s…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
Robot scalpel takes on Alzheimer's: tiny neck surgery aims to clear brain waste
Disease control Recruiting nowThe objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic …
Phase: NA • Sponsor: MMI (Medical Microinstruments, Inc.) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for metastatic prostate cancer? early trial of GLR2037 begins
Disease control Not yet recruitingA Phase I Clinical Study of GLR2037 in Patients with Advanced Prostate Cancer
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New imaging technique aims to sharpen prostate cancer radiation
Knowledge-focused Recruiting nowThis research study is for men with intermediate- or high-risk prostate cancer who are planning to receive hormone therapy and radiation treatment. The purpose of the study is to see whether a special type of diagnostic imaging done during hormone therapy can help doctors more ac…
Phase: PHASE2 • Sponsor: Martin T. King, MD, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Herbal hope: ashwagandha trial targets minority stress in LGBTQ+ community
Symptom relief Recruiting nowSexual and gender minority adults often experience elevated levels of chronic stress due to stigma, discrimination, and social adversity, commonly referred to as minority stress. This persistent stress is associated with increased anxiety, mood disturbances, impaired sleep qualit…
Phase: NA • Sponsor: SF Research Institute, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can an ancient herb boost Women's sexual health? new trial seeks answers
Symptom relief Recruiting nowThis randomized, double-blind, placebo-controlled clinical study is designed to evaluate the efficacy and safety of a standardized Shatavari (Asparagus racemosus) root extract (SRI-81) in improving women's sexual wellness. Sexual wellness is assessed as a multidimensional constru…
Phase: NA • Sponsor: SF Research Institute, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple dental procedure save teeth with extremely deep cavities?
Disease control Recruiting nowThe aim of the study is to compare the clinical and radiographic outcomes of direct pulp capping for deep and extremely deep caries in mature permanent mandibular molars with reversible pulpitis. Primary objective of the study is to evaluate the clinical and radiographic success …
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
E-Cig flavors tested as tool to cut smoking in opioid patients
Disease control Recruiting nowThis project aims to investigate the impact of e-cigarette flavors and usage patterns on achieving harm-reduction milestones in a sample of cigarette smokers with opioid use disorder who are taking buprenorphine
Phase: NA • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New heart device aims to cut stroke risk without lifelong pills
Disease control Recruiting nowThis early feasibility study is intended to evaluate the safety and feasibility of the Append System for eliminating the left atrial appendage (LAA) through a transcatheter procedure that invaginates and ligates the LAA tissue.
Phase: NA • Sponsor: Append Medical Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug trial aims to tame rare clotting disorder
Disease control Recruiting nowThis is a phase II, single-centre, open-label pilot study evaluating the safety and tolerability of anifrolumab in adult patients with primary antiphospholipid syndrome (APS). Approximately 20 participants will receive 120 mg subcutaneous anifrolumab once weekly for up to 52 week…
Phase: PHASE2 • Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Prenatal genome sequencing: helpful or just worrying?
Knowledge-focused Recruiting nowThis study looks at whether genome sequencing should be used more routinely during pregnancy, even when ultrasounds look normal. Genome sequencing can examine nearly all of a baby's genes and may find genetic conditions that standard tests do not detect. Researchers will compare …
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New fibromyalgia drug shows promise in Long-Term safety trial
Symptom relief ENROLLING_BY_INVITATIONThis is a Phase 3, multi-center, 52-week, open-label trial to evaluate the long-term safety and efficacy of AXS-14 in the management of fibromyalgia.
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Could spinal anesthesia cut bleeding risk in prostate surgery?
Knowledge-focused Recruiting nowOpen simple prostatectomy is still performed for selected patients with benign prostatic hyperplasia, particularly in cases with large prostate volume. Postoperative bleeding, hematuria, clot retention, and transfusion requirement are clinically important complications after this…
Phase: NA • Sponsor: Hitit University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a virtual program led by parents cut wait times for eating disorder care?
Symptom relief Recruiting nowEating disorders are amongst the most understudied illnesses affecting young women in Canada. Further, mortality rates are amongst the highest of all psychiatric illnesses. Despite their high prevalence and mortality rates, research into adolescent eating disorders is underfunded…
Phase: NA • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Nordiet diet tested as a natural way to ease IBD symptoms
Disease control Recruiting nowThe aims of the study are 1. to determine the effect on dysbiosis, permeability and inflammatory activity after administration of a Mediterranean like diet (a Nordic equivalent, "Nordiet"), 2. to investigate life style related factors, such as exercise, psychosexual health and qu…
Phase: NA • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Probiotic drink may soothe menopause skin woes
Symptom relief Recruiting nowThis study will explore whether a daily probiotic drink containing Lactobacillus casei Shirota (LcS) can help improve immune function and reduce inflammation in women going through the menopausal transition. Hormonal changes during this stage of life can affect the immune system,…
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New hope for tough prostate cancer? early trial launches
Disease control Recruiting nowThe primary objective of this trial is to determine the safety profile of xaluritamig at the proposed regimen in adult participants with metastatic castration-resistant prostate cancer (mCRPC).
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Gold nanoparticles join fight against advanced melanoma in tiny safety trial
Disease control Recruiting nowAdvanced melanoma is a highly aggressive malignancy that frequently exhibits resistance to conventional radiotherapy and single-agent immunotherapy. This study aims to evaluate the safety and tolerability of an innovative melanoma-specific aggregable gold nanosystem (Au-TMP) in p…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Reishi mushroom tested as fatty liver treatment in new study
Disease control ENROLLING_BY_INVITATIONThis RCT investigates the impact of Ganoderma lucidum on antioxidant staus, NRF2 levels and lipid metabolism in individuals with Metabolic Associated Fatty Liver Disease.
Phase: NA • Sponsor: University of Agriculture, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Magnetic therapy may ease pain after hip surgery
Symptom relief Not yet recruitingThis study aims to verify whether high-intensity pulsed electromagnetic fields (HI-PEMF) can be effectively applied to postoperative total hip arthroplasty patients. Using pain and function as the primary assessment indicators, the study explores the effects of HI-PEMF on postope…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC